The 24 analysts offering 12-month price forecasts for Gilead Sciences Inc have a median target of 83.00, with a high estimate of 96.00 and a low estimate of 63.00. The median estimate represents a -3.78% decrease from the last price of 86.26.
The current consensus among 30 polled investment analysts is to Hold stock in Gilead Sciences Inc. This rating has held steady since November, when it was unchanged from a Hold rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $1.50
Reporting Date Feb 07
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.